Metabolic profiling of glycerophospholipid synthesis in fibroblasts loaded with free cholesterol and modified low density lipoproteins.
Currently, the detailed regulation of major pathways of glycerophospholipid synthesis upon cholesterol loading is largely unknown. Therefore, a detailed lipid metabolic profiling using stable isotope-labeled choline, ethanolamine, and serine was performed by quantitative electrospray ionization tandem mass spectrometry (ESI-MS/MS) in free cholesterol (FC), oxidized (Ox-LDL) and enzymatically modified LDL (E-LDL)-loaded primary human skin fibroblasts. As previously described, an adaptive induction of phosphatidylcholine (PC) synthesis via CDP-choline was found upon FC loading. In contrast to PC, CDP-ethanolamine-mediated phosphatidylethanolamine (PE) synthesis was inhibited by FC incubation. Furthermore, FC induced a shift toward polyunsaturated PE and PC species, which was mediated primarily by PE biosynthesis but not PE remodeling, whereas PC species were shifted mainly by fatty acid (FA) remodeling of existing PC. Modified lipoprotein incubation revealed rather different effects on glycerophospholipid synthesis. E-LDL greatly enhanced PC synthesis, whereas Ox-LDL did not change PC synthesis. Addition of different free FAs (FFA) with and without FC coincubation, as major components of E-LDL, clearly indicated an incorporation of FFA into newly synthesized PC and PE species as well as FFA as important driving force for PC synthesis. Because FC and FFA are known to affect lipid membrane properties including membrane curvature, these data support that CTP:phosphocholine cytidylyl-transferase activity and consequently PC synthesis are regulated by modulation of membrane characteristics at the cellular level. In conclusion, the application of high throughput metabolic profiling of major glycerophospholipid pathways by ESI-MS/MS is a powerful tool to unravel mechanisms underlying the regulation of cellular lipid metabolism.
Binder
Marion
M
Institute of Clinical Chemistry, University of Regensburg, 93042 Regensburg, Germany.
Liebisch
Gerhard
G
Institute of Clinical Chemistry, University of Regensburg, 93042 Regensburg, Germany.
Langmann
Thomas
T
Institute of Clinical Chemistry, University of Regensburg, 93042 Regensburg, Germany.
Schmitz
Gerd
G
Institute of Clinical Chemistry, University of Regensburg, 93042 Regensburg, Germany. Electronic address: gerd.schmitz@klinik.uni-regensburg.de.
D002784:Cholesterol / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D020404:Glycerophospholipids / Q000096:biosynthesis*; D006801:Humans; D007554:Isotopes; D050356:Lipid Metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008660:Metabolism; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010714:Phosphatidylethanolamines / Q000096:biosynthesis; D012867:Skin / Q000166:cytology; D021241:Spectrometry, Mass, Electrospray Ionization
D020404:Glycerophospholipids; D007554:Isotopes; D008077:Lipoproteins, LDL; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D002784:Cholesterol